AstraZeneca (AZN) Earnings
|
Expand Research on AZN
| Next EPS Date | 7/27/26 | EPS Growth Rate | +15.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +83.2% | Revenue Growth Rate | +7.0% |
| Average % Move 1-Wk after EPS | +3.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/27/26  |
Q226 | N/A | $2.50 | N/A | N/A | $15.47B | N/A | N/A | N/A | ||
| 4/29/26 |
Q126 | $2.58 | $2.52 | +$0.06 | $15.29B | $14.9B | N/A |  | | Details | |
| 2/10/26 | Q425 | $2.12 | N/A | N/A | $15.5B | N/A | N/A | | | Details | |
| 11/6/25 | Q325 | $2.38 | $1.16 | +$1.22 | $15.19B | $14.76B | N/A | | | Details | |
| 7/29/25 | Q225 | $2.17 | $1.09 | +$1.08 | $14.46B | $14.09B | N/A | | | Details | |
| 4/29/25 |
Q125 | $2.49 | $1.10 | +$1.39 | $13.59B | $13.77B | N/A | | | Details | |
| 2/6/25 | Q424 | $2.09 | $1.06 | +$1.03 | $14.89B | $14.15B | N/A | | | Details | |
| 11/12/24 | Q324 | $2.08 | $1.02 | +$1.06 | $13.57B | $13.06B | N/A | | | Details |
